Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | MEDI3617 |
Trade Name | |
Synonyms | |
Drug Descriptions |
MEDI3617 is an human monoclonal antibody that prevents the binding of angiopoietin 2 to the Tie2 receptor in vitro, and inhibits angiogenesis and tumor growth in vivo (PMID: 22327175, PMID: 29559563). |
DrugClasses | |
CAS Registry Number | 1415642-51-1 |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Bevacizumab + MEDI3617 | Bevacizumab MEDI3617 | 0 | 0 |
Carboplatin + MEDI3617 + Paclitaxel | Carboplatin MEDI3617 Paclitaxel | 0 | 0 |
MEDI3617 | MEDI3617 | 0 | 2 |
MEDI3617 + Paclitaxel | MEDI3617 Paclitaxel | 0 | 0 |